The first stop for professional medicines advice

Training and Development

75 results

Applied filters

A person-centred approach to polypharmacy and medication review

17 January 2025This article outlines how to identify, invite and apply a person-centred framework to support structured medication review.

Accredited training for pharmacy staff within technical services

17 March 2023Pharmacy staff involved in the preparation of aseptically-prepared products should be suitably trained and accredited to assure a safe service

Adverse drug reactions: resources to support answering questions

30 November 2022Suggested resources to help primary care healthcare professionals find information to answer questions about side-effects of medicines

Advising on medicines during breastfeeding

4 December 2020Most medicines can be used throughout breastfeeding, in some cases further risk-reducing methods may be required

Assessing liver function and interpreting liver blood tests

1 May 2024We explain how to assess liver function including the purpose of liver blood tests, how to interpret them and what to do if they are abnormal.

Assessing risk and informing the risk versus benefit decision for medicines in pregnancy

29 July 2021There are key factors to be considered in making a risk assessment and a risk versus benefit decision about use of medicines in pregnancy.

Assessing the impact of renal impairment on medicines safety

16 December 2022We advise on points to consider when undertaking medication reviews in adults with kidney disorders

Atrial fibrillation management in frail older people

2 December 2022Guidance to help upskill primary and secondary care clinicians in decision making when managing atrial fibrillation in frail older people

Auditing Patient Group Directions

14 September 2020SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Calculating and using the Child-Pugh score

17 May 2024The Child-Pugh score is used to estimate the severity of liver disease in patients with cirrhosis, and by drug manufacturers to suggest dose adjustments.